Scaffold and cell line based approaches for QSAR studies on anticancer agents

被引:9
|
作者
Satbhaiya, Shruti [1 ]
Chourasia, O. P. [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Heterocycl Res Lab, Sagar 470003, MP, India
关键词
BIOLOGICAL EVALUATION; NATURAL-PRODUCTS; DRUG DISCOVERY; 3D QSAR; MOLECULAR DOCKING; DERIVATIVES; DESIGN; PREDICTION; DESCRIPTORS; PERSPECTIVE;
D O I
10.1039/c5ra18295f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Based on a linear heuristic method, a quantitative structure-activity relationship was developed for the prediction of available in vitro anticancer activity. Each type of compound was represented by several calculated structural descriptors. Most of the computational studies were carried out targeting an insufficient number of cell lines. Predictive models were built for 482 compounds with experimental data against 30 different cancer cell lines. Strong statistical analysis showed a high correlation, cross validation coefficient values and provided a range of QSAR equations. Quantum chemical descriptors were found in 42 out of 46 models, electrostatic in 16, topological in 12, geometrical in 7, thermodynamic in 5 and constitutional in 7. It is interesting to note that in most cases, three descriptor-based models were relevant. Pancreatic cancer cell lines showed the best statistical values (average R-2 = 0.87) followed by leukaemia (average R-2 = 0.86).
引用
收藏
页码:84810 / 84820
页数:11
相关论文
共 50 条
  • [1] 2-Indolinone: An Anticancer Scaffold, Overview of the Studies and Approaches (2017-2024)
    Koulani, Taha
    Temizer, Asu Busra
    Karali, Nilgun
    CHEMISTRYSELECT, 2025, 10 (05):
  • [2] Pyrazole scaffold: A remarkable tool in the development of anticancer agents
    Kumar, Harish
    Saini, Deepika
    Jain, Sandeep
    Jain, Neelam
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 70 : 248 - 258
  • [3] Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
    Asati, Vivek
    Anant, Arjun
    Patel, Preeti
    Kaur, Kamalpreet
    Gupta, G. D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 225
  • [4] Rhodanine Derivatives as Anticancer Agents: QSAR and Molecular Docking Studies
    Molnar, Maja
    Loncaric, Melita
    Opacak-Bernardi, Teuta
    Glavas-Obrovac, Ljubica
    Rastija, Vesna
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (07) : 839 - 846
  • [5] QSAR Modeling of the Arylthioindole Class of Colchicine Polymerization Inhibitors as Anticancer Agents
    Habibpour, Elnaz
    Ahmadi, Shahin
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2017, 13 (02) : 143 - 159
  • [6] QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity
    Alam, Sarfaraz
    Khan, Feroz
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (09) : 2373 - 2390
  • [7] In-silico studies of 2-aminothiazole derivatives as anticancer agents by QSAR, molecular docking, MD simulation and MM-GBSA approaches
    Chitre, Trupti S.
    Hirode, Purvaj V.
    Lokwani, Deepak K.
    Bhatambrekar, Aniket L.
    Hajare, Sayli G.
    Thorat, Shubhangi B.
    Priya, D.
    Pradhan, Kunal B.
    Asgaonkar, Kalyani D.
    Jain, Shirish P.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (21) : 11396 - 11414
  • [8] Novel hybrid molecules based on triazole-quinoline as potential anticancer agents: screening on MCF-7 cell line, docking studies, and pharmacokinetics evaluation
    Chaitanya, V. Krishna
    Jalapathi, P.
    Chandar, M. Ravi
    Vishnu, T.
    Veerabhadraiah, M.
    Raghavender, M.
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2023, 20 (04) : 995 - 1006
  • [9] Synthesis and Human Anticancer Cell Line Studies on Coumarin-β-carboline Hybrids as Possible Antimitotic Agents
    Samundeeswari, S.
    Kulkarni, Manohar V.
    Joshi, Shrinivas D.
    Dixit, Sheshagiri R.
    Jayakumar, Srinivasan
    Ezhilarasi, R. M.
    CHEMISTRYSELECT, 2016, 1 (15): : 5019 - 5024
  • [10] Medicinal attributes of pyridine scaffold as anticancer targeting agents
    Mohamed, Esraa Ali
    Ismail, Nasser S. M.
    Hagras, Mohamed
    Refaat, Hanan
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)